Please assess the completion status of the following clinical trial:

Trial Title: ENTegral Artificial Larynx Clinical Trial

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Age more than or equal to 18 years old~* Is indicated for total laryngectomy (first intention)~* Must be able to comply with study requirements~* Must be able to understand and be willing to provide written informed consent~Exclusion Criteria:~* Any condition that precludes the implantation of the ENTegral AL~* Existing coagulation disorder~* Contraindication for general anesthesia~* Tumoral extension outside of the larynx invading through extra-laryngeal structures~* Previous radiotherapy~* Life-expectancy \< 12 months~* Be pregnant of breastfeeding or intention to becoming pregnant during study

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- ENTegral Artificial Larynx implant (Type: EXPERIMENTAL): ENTegral Artificial Larynx implantation

Based on this trial design, predict the completion outcome and termination type (if applicable).